ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-methyl-N-nitrosurea |
|
| Accession: | CHEBI:50102
|
browse the term
|
| Definition: | An urea that has formula C2H5N3O2. |
| Synonyms: | exact_synonym: | 1-methyl-1-nitrosourea |
| | related_synonym: | 1-(aminocarbonyl)-1-methyl-2-oxohydrazine; 1-nitroso-1-methylurea; C2H5N3O2; CN(N=O)C(N)=O; InChI=1S/C2H5N3O2/c1-5(4-7)2(3)6/h1H3,(H2,3,6); InChIKey=ZRKWMRDKSOPRRS-UHFFFAOYSA-N; MNU; Methylnitrosoharnstoff; Methylnitrosourea; N-Methyl-N-nitrosoharnstoff; N-Methyl-N-nitrosourea; N-Nitroso-N-methylharnstoff; N-methyl-N-nitrosocarbamide; N-methyl-N-nitrosouree; N-nitroso-N-methylcarbamide; N-nitroso-N-methylurea; N-nitroso-N-methyluree; N-nitrosomethylurea; NMH; NMU; methylnitrosouree; nitrosomethylurea |
| | alt_id: | CHEBI:25565; CHEBI:34843; CHEBI:50101 |
| | xref_casrn: | 684-93-5 |
| | xref: | Beilstein:1756040 "Beilstein Registry Number"; ChEMBL:153679 "ChEMBL COMPOUND"; ChemIDplus:684-93-5 "CAS Registry Number"; KEGG COMPOUND:684-93-5 "CAS Registry Number"; KEGG COMPOUND:C14595 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D008770 |
| | xref: | NIST Chemistry WebBook:684-93-5 "CAS Registry Number" |
|
|
N-methyl-N-nitrosurea
|
| G |
a |
nonagouti |
|
increases mutagenesis |
EXP |
2 |
154,839,306 |
154,876,748 |
RGD:6480464 |
CTD |
| G |
a |
nonagouti |
|
increases mutagenesis |
EXP |
2 |
154,839,306 |
154,876,748 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
ISO |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases mutagenesis |
ISO |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
|
increases expression |
ISO |
16 |
85,794,072 |
85,803,360 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha fetoprotein |
|
decreases response to substance |
ISO |
5 |
90,919,740 |
90,937,933 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
increases expression |
ISO |
3 |
20,213,395 |
20,266,099 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
ISO |
6 |
34,304,164 |
34,318,454 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt2 |
thymoma viral proto-oncogene 2 |
|
multiple interactions |
ISO |
7 |
28,376,579 |
28,424,472 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatosis polyposis coli |
|
increases response to substance |
EXP |
18 |
34,380,638 |
34,481,844 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase |
|
decreases expression |
ISO |
6 |
7,625,171 |
7,643,182 |
RGD:6480464 |
CTD |
| G |
Atp6v1f |
ATPase, H+ transporting, lysosomal V1 subunit F |
|
increases mutagenesis |
EXP |
6 |
29,417,783 |
29,420,509 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
EXP |
9 |
95,758,016 |
95,852,063 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
affects localization |
EXP |
9 |
95,758,016 |
95,852,063 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
multiple interactions |
ISO |
2 |
172,181,696 |
172,196,006 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
2 |
172,181,696 |
172,196,006 |
RGD:6480464 |
CTD |
| G |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
|
increases expression |
ISO |
2 |
67,955,770 |
67,960,747 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B cell leukemia/lymphoma 10 |
|
increases expression |
ISO |
3 |
145,587,342 |
145,597,247 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
EXP |
9 |
75,623,172 |
75,746,824 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
EXP |
9 |
75,623,172 |
75,746,824 |
RGD:6480464 |
CTD |
| G |
Bpnt1 |
bisphosphate 3'-nucleotidase 1 |
|
increases mutagenesis |
EXP |
1 |
187,156,038 |
187,181,648 |
RGD:6480464 |
CTD |
| G |
Btg2 |
B cell translocation gene 2, anti-proliferative |
|
increases expression |
EXP |
1 |
135,971,442 |
135,975,732 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1 |
|
decreases activity |
ISO |
19 |
5,988,545 |
6,015,825 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
increases activity |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Car2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
3 |
14,886,426 |
14,900,770 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
ISO |
16 |
93,608,082 |
93,610,594 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
11 |
83,476,086 |
83,478,185 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
EXP |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
EXP |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
ISO |
17 |
47,642,000 |
47,736,638 |
RGD:6480464 |
CTD |
| G |
Cd59b |
CD59b antigen |
|
multiple interactions |
ISO |
2 |
103,911,167 |
103,925,114 |
RGD:6480464 |
CTD |
| G |
Cd59b |
CD59b antigen |
|
multiple interactions |
ISO |
2 |
103,911,167 |
103,925,114 |
RGD:6480464 |
CTD |
| G |
Cdh22 |
cadherin 22 |
|
decreases expression |
ISO |
2 |
164,937,007 |
165,060,237 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
increases cleavage |
ISO |
11 |
80,290,548 |
80,294,681 |
RGD:6480464 |
CTD |
| G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
|
increases mutagenesis |
EXP |
2 |
154,161,122 |
154,198,455 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
decreases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
increases expression |
EXP |
2 |
28,411,339 |
28,418,882 |
RGD:6480464 |
CTD |
| G |
Cela2a |
chymotrypsin-like elastase family, member 2A |
|
increases expression |
EXP |
4 |
141,370,878 |
141,381,918 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
increases phosphorylation |
EXP |
5 |
111,269,036 |
111,303,152 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
5 |
111,269,036 |
111,303,152 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
decreases expression |
ISO |
11 |
69,779,003 |
69,781,380 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
decreases expression |
ISO |
1 |
82,583,496 |
82,718,634 |
RGD:6480464 |
CTD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
decreases expression |
ISO |
1 |
82,583,496 |
82,718,634 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
decreases expression |
ISO |
9 |
20,574,494 |
20,619,478 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
increases mutagenesis |
EXP |
10 |
94,637,380 |
94,786,731 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
ISO |
18 |
3,266,352 |
3,337,587 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
EXP |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
decreases expression |
ISO |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
increases mutagenesis |
EXP |
1 |
74,238,359 |
74,241,205 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
10 |
126,485,302 |
126,490,062 |
RGD:6480464 |
CTD |
| G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
|
decreases expression |
ISO |
4 |
96,235,120 |
96,258,176 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor |
|
increases expression |
ISO |
1 |
122,009,857 |
122,017,673 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site albumin promoter binding protein |
|
decreases expression |
ISO |
7 |
52,960,617 |
52,965,573 |
RGD:6480464 |
CTD |
| G |
Depdc7 |
DEP domain containing 7 |
|
increases expression |
ISO |
2 |
104,561,941 |
104,582,958 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
multiple interactions |
ISO |
4 |
106,964,070 |
106,979,748 |
RGD:6480464 |
CTD |
| G |
Dlgap1 |
discs, large (Drosophila) homolog-associated protein 1 |
|
increases mutagenesis |
EXP |
17 |
70,774,132 |
71,170,753 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
EXP |
7 |
138,175,590 |
138,265,142 |
RGD:6480464 |
CTD |
| G |
Dnpep |
aspartyl aminopeptidase |
|
decreases activity |
ISO |
1 |
75,305,140 |
75,314,212 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
ISO |
19 |
53,603,808 |
53,615,812 |
RGD:6480464 |
CTD |
| G |
Dym |
dymeclin |
|
increases mutagenesis |
EXP |
18 |
75,178,426 |
75,446,620 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
|
increases mutagenesis |
EXP |
7 |
29,610,357 |
29,617,258 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases mutagenesis |
EXP |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Eed |
embryonic ectoderm development |
|
affects response to substance |
EXP |
7 |
97,103,164 |
97,129,486 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
|
increases expression |
ISO |
3 |
129,235,304 |
129,341,413 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
increases expression |
EXP |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
decreases expression |
EXP |
16 |
13,109,829 |
13,152,102 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
increases expression |
EXP |
16 |
13,109,829 |
13,152,102 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases response to substance |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases phosphorylation |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
17 |
6,942,480 |
6,987,129 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
increases expression |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
increases expression |
ISO |
4 |
129,986,022 |
129,992,707 |
RGD:6480464 |
CTD |
| G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
|
increases expression |
ISO |
15 |
99,327,436 |
99,358,448 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 |
|
multiple interactions |
ISO |
18 |
38,998,327 |
39,078,353 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
multiple interactions |
ISO |
8 |
26,629,244 |
26,686,186 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
multiple interactions |
ISO |
13 |
55,254,179 |
55,270,120 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
decreases expression |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
decreases expression |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
increases methylation |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
decreases expression |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
multiple interactions |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
decreases expression |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Galnt16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
increases mutagenesis |
EXP |
12 |
81,619,977 |
81,704,883 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
11 |
102,748,650 |
102,758,514 |
RGD:6480464 |
CTD |
| G |
Gh |
growth hormone |
|
decreases response to substance |
ISO |
11 |
106,161,582 |
106,163,124 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases response to substance |
EXP |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
increases mutagenesis |
EXP |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
increases carbamoylation |
ISO |
11 |
32,183,672 |
32,184,486 |
RGD:6480464 |
CTD |
| G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
|
increases carbamoylation |
ISO |
11 |
32,196,492 |
32,197,310 |
RGD:6480464 |
CTD |
| G |
Hesx1 |
homeobox gene expressed in ES cells |
|
increases mutagenesis |
EXP |
14 |
27,813,548 |
27,815,512 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
5 |
16,059,368 |
16,125,257 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
EXP |
5 |
16,059,368 |
16,125,257 |
RGD:6480464 |
CTD |
| G |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
|
increases expression |
ISO |
10 |
13,686,185 |
13,871,184 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
ISO |
8 |
59,990,640 |
59,994,796 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hprt |
hypoxanthine guanine phosphoribosyl transferase |
|
increases mutagenesis |
ISO |
X |
50,341,255 |
50,374,837 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
multiple interactions |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
decreases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases mutagenesis |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases mutagenesis |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
increases response to substance |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases response to substance |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases response to substance |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
multiple interactions |
EXP |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
EXP |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases response to substance |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
increases expression |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igh-7 |
immunoglobulin heavy chain 7 (heavy chain of IgE) |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igh-7 |
immunoglobulin heavy chain 7 (heavy chain of IgE) |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
EXP |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il17b |
interleukin 17B |
|
increases expression |
ISO |
18 |
61,847,589 |
61,852,191 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Inadl |
InaD-like (Drosophila) |
|
increases expression |
EXP |
4 |
98,062,517 |
98,386,294 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
ISO |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
decreases response to substance |
EXP |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
EXP |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases phosphorylation |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases phosphorylation |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
increases expression |
ISO |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Kif3b |
kinesin family member 3B |
|
increases mutagenesis |
EXP |
2 |
153,117,152 |
153,159,126 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
decreases expression |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
multiple interactions |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Klk1b22 |
kallikrein 1-related peptidase b22 |
|
increases expression |
EXP |
7 |
51,368,053 |
51,372,246 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases mutagenesis |
EXP |
6 |
145,165,219 |
145,198,751 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
decreases response to substance |
ISO |
6 |
145,165,219 |
145,198,751 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases mutagenesis |
EXP |
6 |
145,165,219 |
145,198,751 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin B |
|
decreases response to substance |
EXP |
17 |
35,331,452 |
35,333,250 |
RGD:6480464 |
CTD |
| G |
Mad2l2 |
MAD2 mitotic arrest deficient-like 2 |
|
increases mutagenesis |
EXP |
4 |
147,514,599 |
147,519,805 |
RGD:6480464 |
CTD |
| G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
|
increases expression |
EXP |
10 |
79,127,319 |
79,131,281 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases response to substance |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases response to substance |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases response to substance |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
decreases expression |
ISO |
18 |
82,644,515 |
82,755,029 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
ISO |
9 |
86,474,970 |
86,589,947 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases alkylation |
ISO |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mipol1 |
mirror-image polydactyly gene 1 homolog (human) |
|
increases mutagenesis |
EXP |
12 |
58,331,412 |
58,558,228 |
RGD:6480464 |
CTD |
| G |
Mlf1 |
myeloid leukemia factor 1 |
|
increases expression |
ISO |
3 |
67,178,019 |
67,203,922 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1 (E. coli) |
|
multiple interactions |
ISO |
9 |
111,130,732 |
111,174,112 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1 (E. coli) |
|
multiple interactions |
EXP |
9 |
111,130,732 |
111,174,112 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1 (E. coli) |
|
affects response to substance |
EXP |
9 |
111,130,732 |
111,174,112 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
ISO |
9 |
7,445,822 |
7,455,975 |
RGD:6480464 |
CTD |
| G |
Mpc1 |
mitochondrial pyruvate carrier 1 |
|
increases expression |
ISO |
17 |
8,476,678 |
8,490,526 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
decreases response to substance |
ISO |
11 |
32,126,505 |
32,132,702 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases response to substance |
ISO |
11 |
32,126,505 |
32,132,702 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases response to substance |
ISO |
11 |
32,126,505 |
32,132,702 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
multiple interactions |
ISO |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
multiple interactions |
EXP |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
affects response to substance |
EXP |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases response to substance |
EXP |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
multiple interactions |
ISO |
17 |
88,374,390 |
88,390,232 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
EXP |
9 |
74,919,013 |
75,071,495 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
EXP |
9 |
74,919,013 |
75,071,495 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
ISO |
3 |
87,775,015 |
87,784,373 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
increases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
decreases expression |
ISO |
2 |
157,385,846 |
157,388,258 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nrxn3 |
neurexin III |
|
decreases expression |
ISO |
12 |
90,191,834 |
91,573,375 |
RGD:6480464 |
CTD |
| G |
Oaf |
OAF homolog (Drosophila) |
|
increases expression |
ISO |
9 |
43,029,361 |
43,047,899 |
RGD:6480464 |
CTD |
| G |
Oca2 |
oculocutaneous albinism II |
|
increases mutagenesis |
EXP |
7 |
63,495,141 |
63,791,887 |
RGD:6480464 |
CTD |
| G |
Oca2 |
oculocutaneous albinism II |
|
increases mutagenesis |
EXP |
7 |
63,495,141 |
63,791,887 |
RGD:6480464 |
CTD |
| G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
|
increases expression |
ISO |
1 |
23,373,263 |
23,390,014 |
RGD:6480464 |
CTD |
| G |
Opn4 |
opsin 4 (melanopsin) |
|
decreases expression |
ISO |
14 |
35,403,804 |
35,413,328 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
increases response to substance |
EXP |
14 |
33,015,157 |
33,110,736 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases response to substance |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
affects response to substance |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases activity |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp2 |
poly (ADP-ribose) polymerase family, member 2 |
|
increases response to substance |
EXP |
14 |
51,427,621 |
51,440,975 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcx |
pyruvate carboxylase |
|
increases expression |
ISO |
19 |
4,510,472 |
4,621,752 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isoenzyme 1 |
|
increases expression |
ISO |
2 |
71,711,329 |
71,741,915 |
RGD:6480464 |
CTD |
| G |
Perp |
PERP, TP53 apoptosis effector |
|
increases expression |
EXP |
10 |
18,564,877 |
18,576,879 |
RGD:6480464 |
CTD |
| G |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
|
increases expression |
ISO |
8 |
125,005,598 |
125,075,229 |
RGD:6480464 |
CTD |
| G |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
|
increases expression |
ISO |
8 |
125,005,598 |
125,075,229 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
multiple interactions |
ISO |
X |
160,857,719 |
160,871,847 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
multiple interactions |
ISO |
X |
160,857,719 |
160,871,847 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
ISO |
X |
160,857,719 |
160,871,847 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
ISO |
X |
160,857,719 |
160,871,847 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase inhibitor beta, cAMP dependent, testis specific |
|
increases expression |
ISO |
10 |
57,351,787 |
57,460,918 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
EXP |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
144,670,870 |
144,692,625 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
affects response to substance |
EXP |
5 |
144,670,870 |
144,692,625 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
increases response to substance |
ISO |
5 |
144,670,870 |
144,692,625 |
RGD:6480464 |
CTD |
| G |
Polb |
polymerase (DNA directed), beta |
|
increases response to substance |
EXP |
8 |
23,738,591 |
23,763,909 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases response to substance |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Prune |
prune homolog (Drosophila) |
|
increases mutagenesis |
EXP |
3 |
95,057,596 |
95,085,998 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
EXP |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pvrl1 |
poliovirus receptor-related 1 |
|
decreases expression |
ISO |
9 |
43,552,659 |
43,615,544 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases mutagenesis |
EXP |
11 |
98,799,010 |
98,836,256 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
ISO |
11 |
98,799,010 |
98,836,256 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
11 |
98,799,010 |
98,836,256 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases phosphorylation |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rbm4 |
RNA binding motif protein 4 |
|
increases mutagenesis |
EXP |
19 |
4,784,293 |
4,793,877 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
increases expression |
ISO |
19 |
38,191,110 |
38,199,811 |
RGD:6480464 |
CTD |
| G |
Reg1 |
regenerating islet-derived 1 |
|
increases expression |
EXP |
6 |
78,375,977 |
78,378,660 |
RGD:6480464 |
CTD |
| G |
Reg3b |
regenerating islet-derived 3 beta |
|
increases expression |
EXP |
6 |
78,320,879 |
78,323,460 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects activity |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
|
increases mutagenesis |
EXP |
10 |
84,218,793 |
84,369,283 |
RGD:6480464 |
CTD |
| G |
Rnase1 |
ribonuclease, RNase A family, 1 (pancreatic) |
|
increases expression |
EXP |
14 |
51,764,677 |
51,766,442 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
affects expression |
ISO |
1 |
169,528,493 |
169,569,754 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
increases expression |
ISO |
3 |
90,404,137 |
90,406,624 |
RGD:6480464 |
CTD |
| G |
Scg2 |
secretogranin II |
|
increases expression |
ISO |
1 |
79,431,244 |
79,436,665 |
RGD:6480464 |
CTD |
| G |
Scn10a |
sodium channel, voltage-gated, type X, alpha |
|
decreases expression |
ISO |
9 |
119,517,584 |
119,603,478 |
RGD:6480464 |
CTD |
| G |
Slc16a12 |
solute carrier family 16 (monocarboxylic acid transporters), member 12 |
|
increases mutagenesis |
EXP |
19 |
34,742,896 |
34,821,601 |
RGD:6480464 |
CTD |
| G |
Slc25a53 |
solute carrier family 25, member 53 |
|
increases expression |
EXP |
X |
133,515,655 |
133,572,841 |
RGD:6480464 |
CTD |
| G |
Slc26a4 |
solute carrier family 26, member 4 |
|
multiple interactions |
ISO |
12 |
32,204,684 |
32,244,834 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases response to substance |
EXP |
18 |
73,798,667 |
73,863,395 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects metabolic processing |
EXP |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
increases expression |
ISO |
11 |
116,393,225 |
116,397,989 |
RGD:6480464 |
CTD |
| G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
|
increases mutagenesis |
EXP |
4 |
40,867,089 |
40,878,428 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spry2 |
sprouty homolog 2 (Drosophila) |
|
increases expression |
ISO |
14 |
106,291,164 |
106,296,036 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
|
increases cleavage |
ISO |
2 |
29,821,080 |
29,886,971 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
increases expression |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Stat4 |
signal transducer and activator of transcription 4 |
|
increases response to substance |
EXP |
1 |
52,065,088 |
52,164,028 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
4 |
134,024,235 |
134,029,758 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
affects expression |
ISO |
X |
7,215,706 |
7,230,382 |
RGD:6480464 |
CTD |
| G |
Tcrg |
T cell receptor gamma chain |
|
increases mutagenesis |
EXP |
13 |
19,269,911 |
19,448,345 |
RGD:6480464 |
CTD |
| G |
Terc |
telomerase RNA component |
|
affects response to substance |
EXP |
3 |
96,218,360 |
96,218,756 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 (spasmolytic protein 1) |
|
increases expression |
EXP |
17 |
31,278,007 |
31,281,227 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
17 |
71,193,545 |
71,202,872 |
RGD:6480464 |
CTD |
| G |
Thpo |
thrombopoietin |
|
multiple interactions |
EXP |
16 |
20,724,527 |
20,734,584 |
RGD:6480464 |
CTD |
| G |
Thpo |
thrombopoietin |
|
increases expression |
EXP |
16 |
20,724,527 |
20,734,584 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
affects expression |
ISO |
14 |
18,493,474 |
18,870,602 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
ISO |
7 |
104,561,467 |
104,566,020 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
ISO |
7 |
104,561,467 |
104,566,020 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
increases expression |
ISO |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
|
increases expression |
ISO |
4 |
129,842,844 |
129,852,366 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
increases expression |
ISO |
14 |
31,362,335 |
31,387,908 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
increases mutagenesis |
EXP |
4 |
116,224,133 |
116,228,548 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
decreases expression |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
ISO |
17 |
23,812,412 |
23,814,416 |
RGD:6480464 |
CTD |
| G |
Tnip2 |
TNFAIP3 interacting protein 2 |
|
increases expression |
ISO |
5 |
34,838,745 |
34,856,628 |
RGD:6480464 |
CTD |
| G |
Top3b |
topoisomerase (DNA) III beta |
|
decreases expression |
EXP |
16 |
16,870,984 |
16,893,079 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases response to substance |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
affects response to substance |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
increases expression |
ISO |
15 |
83,394,003 |
83,404,633 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
EXP |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
EXP |
4 |
80,480,134 |
80,497,622 |
RGD:6480464 |
CTD |
| G |
Ubac2 |
ubiquitin associated domain containing 2 |
|
increases mutagenesis |
EXP |
14 |
122,277,828 |
122,420,257 |
RGD:6480464 |
CTD |
| G |
Ube2j1 |
ubiquitin-conjugating enzyme E2J 1 |
|
increases expression |
ISO |
4 |
33,118,400 |
33,139,339 |
RGD:6480464 |
CTD |
| G |
Ube2j1 |
ubiquitin-conjugating enzyme E2J 1 |
|
increases expression |
ISO |
4 |
33,118,400 |
33,139,339 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases expression |
ISO |
11 |
9,018,011 |
9,036,173 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-related MMTV integration site 5A |
|
increases expression |
ISO |
14 |
29,318,659 |
29,338,620 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases response to substance |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
| G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
increases mutagenesis |
EXP |
1 |
72,353,995 |
72,441,527 |
RGD:6480464 |
CTD |
| G |
Zfp128 |
zinc finger protein 128 |
|
increases expression |
ISO |
7 |
13,466,527 |
13,478,771 |
RGD:6480464 |
CTD |
| G |
Zfp128 |
zinc finger protein 128 |
|
increases expression |
ISO |
7 |
13,466,527 |
13,478,771 |
RGD:6480464 |
CTD |
Term paths to the root
|